Compound
a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E))
A glycopentaosylceramide having α-L-Fuc-(1→2)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc as the glycopentaosyl component.
Definition from ChEBI (CHEBI:28691), read 2026-09-23. CC BY 4.0.
Structure
- Class
- Organic compound
- Formula
- C51H89N2O27R
- Mass
- 1162.252 g/mol
- Charge
- 0
- SMILES
- *C(=O)N[C@@H](CO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@@H]3O[C@H](CO)[C@@H](O[C@@H]4O[C@H](CO)[C@H](O)[C@H](O)[C@H]4O[C@@H]4O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]4O)[C@H](O)[C@H]3NC(C)=O)[C@H]2O)[C@H](O)[C@H]1O)[C@H](O)/C=C/CCCCCCCCCCCCC
- Look it up
- ChEBI
Identity from ChEBI. Not evidence.
What it touches on the way
Mechanistic reach
1 entity
1 entities reached.
0 reported hops1 assembled from the scaffold
What the reference databases state
Statements
1 statement
1 statement · 1 reference database · Subject: a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E)) · Sources: Rhea
- a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E)) is a substrate of FUCA1ProteinRhea RHEA:48224Inferred only
Reactions
3 reactions
CHEBI:28471+watera neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E))+CHEBI:40356
Catalysed by NAGA
Reaction pageLeft to rightBalance undeterminable
Rhea RHEA:48212CC BY 4.0Reference data
a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E))+watera neolactoside nLc4Cer(d18:1(4E))+L-fucose
Catalysed by FUCA1
Reaction pageLeft to rightBalance undeterminable
Rhea RHEA:48224CC BY 4.0Reference data
a neolactoside nLc4Cer(d18:1(4E))+GDP-beta-L-fucosea neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E))+GDP+hydron
Reaction pageLeft to rightBalance undeterminable
Rhea RHEA:48304CC BY 4.0Reference data
Other names
21 names
Resolves to: a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E))
- Also called
- (Gal)2 (Glc)1 (GlcNAc)1 (LFuc)1 (Cer)1alpha-Fuc-(1->2)-beta-Gal-(1->4)-beta-GlcNAc-(1->3)-beta-Gal-(1->4)-beta-Glc-(1->1')-Ceralpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(11')-N-acyl-sphing-4-eninealpha-L-fucosyl-(1->2)-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramidealpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1->1')-CerFucalpha1->2Galbeta1->4GlcNAcbeta1->3Galbeta1->4Glcbetal->CerFucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbeta-CerFucalpha1-2Galbeta1-4GlcNAcbeta1-3Galbeta1-4Glcbetal-1CerFucα1-2Galβ1-4GlcNAcβ1-3Galβ1-4Glcβl-1CerFucα1→2Galβ1→4GlcNAcβ1→3Galβ1→4Glcβl→CerH1 glycolipid, type II antigenIV2-a-Fuc-nLc4CerIV2Fuc-nLc4CerN-[(2S,3R,4E)-1-{[6-deoxy-alpha-L-galactopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]acetamideN-[(2S,3R,4E)-1-{[6-deoxy-α-L-galactopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]acetamideType IIH glycolipidα-Fuc-(1→2)-β-Gal-(1→4)-β-GlcNAc-(1→3)-β-Gal-(1→4)-β-Glc-(1→1')-Cerα-L-fucosyl-(1→2)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosylceramideα-L-Fucp-(1→2)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1→1')-Cer
- Systematic name
- N-[(2S,3R,4E)-1-{[alpha-L-fucopyranosyl-(1->2)-beta-D-galactopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-D-glucopyranosyl-(1->3)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamideN-[(2S,3R,4E)-1-{[α-L-fucopyranosyl-(1→2)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide